AEV-103

N/A

Report date: 2022/05/16 11:29:45
NME

Base Information

Drug NameAEV-103
Drug Alias Name3,6'-DP3,6'-dithiopomalidomideAEV103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsAlzheimer DiseaseBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthYonsei UniversityNational Institute On Aging (NIA) +[4] 
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseBrain Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A